Emergent BioSolutions to Participate in June 2010 Investor Conferences
ROCKVILLE, Md., Jun 01, 2010 (BUSINESS WIRE) –Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be participating in the following investor conferences during June 2010.
- The Jefferies & Company 2010 Global Life Sciences Conference
New York, NY.
June 8, 2010
Corporate Overview Presentation
11:00 AM Eastern
There will be a full webcast with slides that will include discussion of the Company’s business activities, financial outlook and current news.
- The Needham & Company 9th Annual Healthcare Conference
New York, NY.
June 10, 2010
Corporate Overview Presentation
3:20 PM Eastern
There will be a full webcast with slides that will include discussion of the Company’s business activities, financial outlook and current news.
Both webcasts will be accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax(R) (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent’s product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia. Additional information may be found at www.emergentbiosolutions.com.
SOURCE: Emergent BioSolutions Inc.
Emergent BioSolutions Inc. Investors Contact: Robert G. Burrows Vice President, Investor Relations 301-795-1877 BurrowsR@ebsi.com or Media Contact: Tracey Schmitt Vice President, Corporate Communications 301-795-1800 SchmittT@ebsi.com